In vitro dynamics of HIV-1 BF intersubtype recombinants genomic regions involved in the regulation of gene expression

Virology Journal

Volumn 6, Issue , 2009, Pages

  Carobene, Mauricio G ^a   Rodrígues, Christian Rodríguez ^a   De Candia, Cristian A ^a   Turk, Gabriela ^a   Salomn, Horacio ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSACTIVATOR PROTEIN; VPR PROTEIN; VPR PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1;

ARTICLE; CONTROLLED STUDY; GENE CONTROL; GENETIC VARIABILITY; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION; SEQUENCE ANALYSIS; VIRUS REPLICATION; ADAPTATION; GENE EXPRESSION REGULATION; GENETIC RECOMBINATION; GENETICS; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONG TERMINAL REPEAT; PHYSIOLOGY; SOUTH AMERICA; VIROLOGY; VIRUS GENOME;

HUMAN IMMUNODEFICIENCY VIRUS 1;

ADAPTATION, BIOLOGICAL; GENE EXPRESSION REGULATION, VIRAL; GENOME, VIRAL; GENOTYPE; HIV INFECTIONS; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; RECOMBINATION, GENETIC; SOUTH AMERICA; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; VPR GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

EID: 68749111034     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-6-107     Document Type: Article

References (33)

1. Genetically stable reassortment of markers during mixed infection with avian tumor viruses. PK Vogt, Virology 1971 46 947 952 10.1016/0042-6822(71) 90093-6 4332983
2. Genetic recombination of human immunodeficiency virus. F Clavel MD Hoggan RL Willey K Strebel MA Martin R Repaske, J Virol 1989 63 1455 1459 2915387
3. Genetic studies of temperature-sensitive mutants of Moloney-murine leukemia virus. PK Wong JA McCarter, Virology 1973 53 319 326 10.1016/0042-6822(73)90209-2 4736498
4. Genetic consequences of packaging two RNA genomes in one retroviral particle: pseudodiploidy and high rate of genetic recombination. WS Hu HM Temin, Proc Natl Acad Sci USA 1990 87 1556 1560 2304918 10.1073/pnas.87.4.1556
5. Retroviral recombination and reverse transcription. WS Hu HM Temin, Science 1990 250 1227 1233 10.1126/science.1700865 1700865
6. A genetic-algorithm approach to simulating human immunodeficiency virus evolution reveals the strong impact of multiply infected cells and recombination. G Bocharov NJ Ford J Edwards T Breinig S Wain-Hobson A Meyerhans, J Gen Virol 2005 86 3109 3118 10.1099/vir.0.81138-0 16227234 (Pubitemid 41555577)
7. Extensive recombination among human immunodeficiency virus type 1 quasispecies makes an important contribution to viral diversity in individual patients. C Charpentier T Nora O Tenaillon F Clavel AJ Hance, J Virol 2006 80 2472 2482 16474154 10.1128/JVI.80.5.2472-2482.2006 (Pubitemid 43271553)
8. HIV-1 sequence variation: drift, shift, and attenuation. MH Malim M Emerman, Cell 2001 104 469 472 10.1016/S0092-8674(01)00234-3 11239404 (Pubitemid 32201943)
9. Recombination increases human immunodeficiency virus fitness, but not necessarily diversity. NN Vijay Vasantika R Ajmani AS Perelson NM Dixit, J Gen Virol 2008 89 1467 1477 10.1099/vir.0.83668-0 18474563
10. Two HIV-1 epidemics in Argentina: different genetic subtypes associated with different risk groups. MM Avila MA Pando G Carrion LM Peralta H Salomon MG Carrillo J Sanchez S Maulen J Hierholzer M Marinello M Negrete KL Russell JK Carr, J Acquir Immune Defic Syndr 2002 29 422 426 11917249
11. Diverse BF recombinants have spread widely since the introduction of HIV-1 into South America. JK Carr M Avila M Gomez Carrillo H Salomon J Hierholzer V Watanaveeradej MA Pando M Negrete KL Russell J Sanchez DL Birx R Andrade J Vinoles FE McCutchan, Aids 2001 15 F41 47 10.1097/00002030-200110190- 00002 11600844 (Pubitemid 32980632)
12. Mother-to-child HIV type 1 transmission in Argentina: BF recombinants have predominated in infected children since the mid-1980s. M Gomez Carrillo M Avila J Hierholzer M Pando PL Martinez FE McCutchan JK Carr, AIDS Res Hum Retroviruses 2002 18 477 483 10.1089/088922202317406619 12015900 (Pubitemid 34499723)
13. HIV type 1 BF recombinant strains exhibit different pol gene mosaic patterns: descriptive analysis from 284 patients under treatment failure. JF Quarleri A Rubio M Carobene G Turk M Vignoles RP Harrigan JS Montaner H Salomon M Gomez-Carrillo, AIDS Res Hum Retroviruses 2004 20 1100 1107 10.1089/aid.2004.20.1100 15585101 (Pubitemid 39392014)
14. Higher transactivation activity associated with LTR and Tat elements from HIV-1 BF intersubtype recombinant variants. G Turk M Carobene A Monczor AE Rubio M Gomez-Carrillo H Salomon, Retrovirology 2006 3 14 16483381 10.1186/1742-4690-3-14 (Pubitemid 44110262)
15. Magnitude, breadth, and functional profile of T-cell responses during human immunodeficiency virus primary infection with B and BF viral variants. G Turk MM Gherardi N Laufer M Saracco R Luzzi JH Cox P Cahn H Salomon, J Virol 2008 82 2853 2866 18184702 10.1128/JVI.02260-07 (Pubitemid 351329176)
16. HIV-1 Vpr transactivates LTR-directed expression through sequences present within -278 to -176 and increases virus replication in vitro. R Vanitharani S Mahalingam Y Rafaeli SP Singh A Srinivasan DB Weiner V Ayyavoo, Virology 2001 289 334 342 10.1006/viro.2001.1153 11689055 (Pubitemid 33141012)
17. Mutagenesis of the putative alpha-helical domain of the Vpr protein of human immunodeficiency virus type 1: effect on stability and virion incorporation. S Mahalingam SA Khan R Murali MA Jabbar CE Monken RG Collman A Srinivasan, Proc Natl Acad Sci USA 1995 92 3794 3798 7731985 10.1073/pnas.92.9.3794
18. The carboxy-terminal domain is essential for stability and not for virion incorporation of HIV-1 Vpr into virus particles. S Mahalingam M Patel RG Collman A Srinivasan, Virology 1995 214 647 652 10.1006/viro.1995.0079 8553570 (Pubitemid 26027794)
19. Phosphorylation of human immunodeficiency virus type 1 Vpr regulates cell cycle arrest. Y Zhou L Ratner, J Virol 2000 74 6520 6527 10864665 10.1128/JVI.74.14.6520-6527.2000 (Pubitemid 30429820)
20. Phosphorylation of Vpr regulates HIV type 1 nuclear import and macrophage infection. I Agostini S Popov T Hao JH Li L Dubrovsky O Chaika N Chaika R Lewis M Bukrinsky, AIDS Res Hum Retroviruses 2002 18 283 288 10.1089/ 088922202753472856 11860675 (Pubitemid 34253146)
21. Localization of HIV-1 Vpr to the nuclear envelope: impact on Vpr functions and virus replication in macrophages. G Jacquot E Le Rouzic A David J Mazzolini J Bouchet S Bouaziz F Niedergang G Pancino S Benichou, Retrovirology 2007 4 84 18039376 10.1186/1742-4690-4-84 (Pubitemid 351167104)
22. Multiple functional domains of Tat, the trans-activator of HIV-1, defined by mutational analysis. M Kuppuswamy T Subramanian A Srinivasan G Chinnadurai, Nucleic Acids Res 1989 17 3551 3561 2542902 10.1093/nar/17.9.3551
23. Genetic analysis of the cofactor requirement for human immunodeficiency virus type 1 Tat function. SJ Madore BR Cullen, J Virol 1993 67 3703 3711 8389901
24. Control of stochastic gene expression by host factors at the HIV promoter. JC Burnett K Miller-Jensen PS Shah AP Arkin DV Schaffer, PLoS Pathog 2009 5 e1000260 19132086 10.1371/journal.ppat.1000260
25. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication. JJ McAllister D Phillips S Millhouse J Conner T Hogan HL Ross B Wigdahl, Virology 2000 274 262 277 10.1006/viro.2000.0476 10964770 (Pubitemid 30683509)
26. HIV-1 Vpr binding to HIV-1 LTR C/EBP cis-acting elements and adjacent regions is sequence-specific. TH Hogan MR Nonnemacher FC Krebs A Henderson B Wigdahl, Biomed Pharmacother 2003 57 41 48 10.1016/S0753-3322(02)00333-5 12642036 (Pubitemid 36315669)
27. Human immunodeficiency virus type 1 (HIV-1) Vpr enhances expression from unintegrated HIV-1 DNA. B Poon IS Chen, J Virol 2003 77 3962 3972 12634356 10.1128/JVI.77.7.3962-3972.2003 (Pubitemid 36350937)
28. Interaction of virion protein Vpr of human immunodeficiency virus type 1 with cellular transcription factor Sp1 and trans-activation of viral long terminal repeat. L Wang S Mukherjee F Jia O Narayan LJ Zhao, J Biol Chem 1995 270 25564 25569 10.1074/jbc.270.43.25564 7592727
29. Human immunodeficiency virus type 1 (HIV-1) accessory protein Vpr induces transcription of the HIV-1 and glucocorticoid-responsive promoters by binding directly to p300/CBP coactivators. T Kino A Gragerov O Slobodskaya M Tsopanomichalou GP Chrousos GN Pavlakis, J Virol 2002 76 9724 9734 12208951 10.1128/JVI.76.19.9724-9734.2002 (Pubitemid 35006513)
30. HIV-1 Vpr-induced apoptosis is cell cycle dependent and requires Bax but not ANT. JL Andersen JL DeHart ES Zimmerman O Ardon B Kim G Jacquot S Benichou V Planelles, PLoS Pathog 2006 2 e127 17140287 10.1371/journal.ppat.0020127 (Pubitemid 46045198)
31. Vpr R77Q is associated with long-term nonprogressive HIV infection and impaired induction of apoptosis. JJ Lum OJ Cohen Z Nie JG Weaver TS Gomez XJ Yao D Lynch AA Pilon N Hawley JE Kim Z Chen M Montpetit J Sanchez-Dardon EA Cohen AD Badley, J Clin Invest 2003 111 1547 1554 12750404
32. Effect of R77Q, R77A and R80A changes in Vpr on HIV-1 replication and CD4 T cell depletion in human lymphoid tissue ex vivo. D Rajan S Wildum E Rucker M Schindler F Kirchhoff, Aids 2006 20 831 836 10.1097/01.aids.0000218546.31716.7f 16549966 (Pubitemid 43731564)
33. A jumping profile Hidden Markov Model and applications to recombination sites in HIV and HCV genomes. AK Schultz M Zhang T Leitner C Kuiken B Korber B Morgenstern M Stanke, BMC Bioinformatics 2006 7 265 16716226 10.1186/1471-2105-7-265 (Pubitemid 44164733)